Updating results

24 results for Alzheimer's disease

Sort: Relevance | Date

Donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease (TA217)

Evidence-based recommendations on donepezil (Aricept), galantamine (Reminyl), rivastigmine (Exelon) and memantine (Ebixa) for treating Alzheimer's disease

Technology appraisal guidance Published March 2011 Last updated June 2018

Dementia: assessment, management and support for people living with dementia and their carers (NG97)

This guideline covers diagnosing and managing dementia (including Alzheimer’s disease). It aims to improve care by making recommendations on training staff and helping carers to support people living with dementia.

NICE guideline Published June 2018

Dementia

Everything NICE has said on assessment, management and support for people living with dementia and Alzheimer's disease and their carers in an interactive flowchart

NICE Pathway Published May 2011 Last updated June 2019

Research is needed on the impact of treating Alzheimer's disease on mortality and institutionalisation, and to assess the relationship between disease progression and carer utility (quality of life).

the impact of treating Alzheimer's disease on mortality and institutionalisation, and to assess the relationship between...

Research recommendation Published June 2015

Hypnotics (KTT6)

This document summarises the evidence base on hypnotics. It is a key therapeutic topic that has been identified to support medicines optimisation. It is not formal NICE guidance.

Key therapeutic topic Published January 2015 Last updated September 2019

Research is needed to generate robust and relevant data on the effects of treating people with Alzheimer's disease on both short-term and long-term outcomes, disease progression through relevant health states, and quality of life.

data on the effects of treating people with Alzheimer's disease on both short-term and long-term outcomes, disease...

Research recommendation Published June 2015

Our projects and partners

NICE research projects and partners.

Published August 2019 Last updated August 2019

Antipsychotics in people living with dementia (KTT7)

This document summarises the evidence base on antipsychotics in people living with dementia. It is a key therapeutic topic that has been identified to support medicines optimisation. It is not formal NICE guidance.

Key therapeutic topic Published January 2015 Last updated September 2019

Static list

NICE technology appraisal guidance static list

Published January 2018 Last updated January 2018

Mental wellbeing of older people in care homes (QS50)

This quality standard covers the mental wellbeing of older people (aged 65 and over) receiving care in care homes (including residential and nursing accommodation, day care and respite care). It focuses on support for people to improve their mental wellbeing so that they can stay as well and independent as possible. It describes high-quality care in priority areas for improvement.

Quality standard Published December 2013

Oral health for adults in care homes (NG48)

This guideline covers oral health, including dental health and daily mouth care, for adults in care homes. The aim is to maintain and improve their oral health and ensure timely access to dental treatment.

NICE guideline Published July 2016

Alzheimer's disease (mild to moderate) - donepezil, rivastigmine and galantamine (TA19)

This guidance has been replaced by NICE technology appraisal guidance 111.

Technology appraisal guidance Published January 2001

Donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease (TA111)

This guidance has been updated and replaced by NICE technology appraisal 217.

Technology appraisal guidance Published November 2006

Improving-oral-health-for-adults-in-care-homes

A quick and easy-to-read guide for care home managers about achieving good oral health in care homes.

Published March 2017 Last updated March 2017

Improving oral health for adults in care homes

A quick and easy-to-read guide for care home managers about achieving good oral health in care homes.

Published January 2019 Last updated January 2019

Dementia, disability and frailty in later life: mid-life approaches to delay or prevent onset

Everything NICE has said on preventing or delaying dementia, disability and frailty in an interactive flowchart

NICE Pathway Published October 2015 Last updated November 2019

Past appeals and decisions

TA ID Appraisal Short title Appeal hearing date TA111 Alzheimer´s disease - donepezil, rivastigmine, galantamine and...

Published May 2019 Last updated May 2019

Being monitored and out of remit procedures

awaiting use in the NHS 1095 / 1 AlphaCore Therapy for Reactive Airway Disease Monitor - used in research only 1102 / 1...

Published August 2019 Last updated August 2019

Dementia (non-Alzheimer) - new pharmaceutical treatments [ID380]

In development [GID-TAG369] Expected publication date: TBC

Technology appraisal guidance In development

Research recommendations

intravenous iron preparations in children with anaemia of chronic kidney disease (CKD), including safety, dosing and efficacy outcomes.

Published April 2016 Last updated April 2016

People with dementia should be offered activities that can help promote wellbeing

People living with dementia should be offered activities such as exercise, aromatherapy, art, gardening, baking, reminiscence therapy, music therapy, mindfulness and animal assisted therapy to help promote their wellbeing.

News Published June 2019 Last updated June 2019

Sharing end of life decisions: Carrying out mum's wishes

Annabel Dawson, lay reviewer for National Institute for Health Research discussed the importance of end of life planning

News Published January 2019 Last updated January 2019

David Haslam: Getting the guidance right

Professor David Haslam spoke to the Royal College of Physicians' Commentary magazine about NICE’s role and new developments

News Published June 2016 Last updated June 2016

NICE takes key role in new European project for faster access to Alzheimer's disease drugs

Patients’ priorities will be brought to the fore in new Alzheimer’s project

News Published January 2017 Last updated January 2017